Anticoagulants in pregnancy: fetal effects (Q41715403)

7 October 2017

1 reference

title

Anticoagulants in pregnancy: fetal effects (English)

1 reference

7 October 2017

1 reference

Bates SM

1

1 reference

7 October 2017

Ginsberg JS

series ordinal

2

1 reference

7 October 2017

publication date

1 September 1997

1 reference

Bailliere's clinical obstetrics and gynaecology

7 October 2017

published in

1 reference

7 October 2017

volume

11

1 reference

7 October 2017

issue

3

1 reference

7 October 2017

page(s)

479-488

1 reference

Follow-up study of children whose mothers were treated with warfarin during pregnancy.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Placental transport of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Use of antithrombotic agents during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Heparin therapy during pregnancy. Risks to the fetus and mother

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Maternal and fetal sequelae of anticoagulation during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Clinical experience with anticoagulant therapy during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

The course of pregnancy in patients with artificial heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Risks of anticoagulant therapy in pregnant women with artificial heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Danger of dicumarol treatment in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

May mothers given warfarin breast-feed their infants?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Low molecular weight heparin in prevention of perioperative thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Is warfarin sodium contraindicated in the lactating mother?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Multiple congenital anomalies associated with oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

THROMBOEMBOLIC DISEASE IN PREGNANCY

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980023-5

7 January 2021

10.1016/S0950-3552(97)80023-5

Identifiers

DOI

1 reference

release_znbwljrzojdozj3j6tmt5xdxlu

7 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/znbwljrzojdozj3j6tmt5xdxlu

24 November 2022

mapped directly with Wikidata item

1 reference